SORT BY

FILTER BY

also on other fortune lists

World's Most Admired Companies

Roche Group

RHHBY

Pharmaceuticals

Looking for leads, investment insights, or competitive intelligence?

Industry

Pharmaceuticals

Location

Basel, Switzerland

Industry Ranking

4

Previous Industry Ranking

2*

Previous Top 50 Ranking

-

Overall Score

6.86

Tie in rank.
Key Attributes of Reputation
Industry Rank
Innovation44%
People Management33%
Use of Corporate Assets22%
Social Responsibility99%
Quality of Management55%
Financial Soundness44%
Long-Term Investment Value44%
Quality of Products/Services55%
Global Competitiveness33%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Roche Group

Japan Just Approved a New Drug That Can Kill the Flu Virus In Just One Day

But Shionogi's Xofluza likely won't be available in the U.S. till at least 2019.

Read More →
Why Drug Giant Roche's $1.9 Billion Deal to Buy Data Startup Flatiron Health Matters

Flatiron is connected with hundreds of cancer treatment centers—and its data collection could spur new drugs.

Read More →
This New Drug Combination Doubles the Chance of Keeping Lung Cancer at Bay

The finding could result in annual sales of $4.6 billion by 2023.

Read More →
Amgen Is Taking On a $3 Billion Cancer Drug. But Will It Cut Costs for Patients?

The FDA approved the first cancer medicine "biosimilar" Thursday.

Read More →